Abstract: The present invention relates to the field of medicine and virology. An attenuated influenza A virus, an influenza virus vector based thereon, and a pharmaceutical composition comprising thereof are provided, which can be used for the prevention and/or treatment of an infectious disease. In addition, the present invention relates to an attenuated influenza A virus, an influenza virus vector based thereon, and a pharmaceutical composition comprising thereof, which can be used for the treatment of oncological diseases.
Type:
Grant
Filed:
November 3, 2016
Date of Patent:
August 27, 2019
Assignee:
PHARMENTERPRISES BIOTECH Limited Liability Company
Inventors:
Andrei Yurievich Egorov, Boris Ferko, Artem Alexandrovich Krokhin, Yulia Romanovna Romanova
Abstract: The present invention relates to the field of medicine and virology. An attenuated influenza A virus, an influenza virus vector based thereon, and a pharmaceutical composition comprising thereof are provided, which can be used for the prevention and/or treatment of an infectious disease. In addition, the present invention relates to an attenuated influenza A virus, an influenza virus vector based thereon, and a pharmaceutical composition comprising thereof, which can be used for the treatment of oncological diseases.
Type:
Application
Filed:
November 3, 2016
Publication date:
August 30, 2018
Applicant:
PHARMENTERPRISES BIOTECH Limited Liability Company
Inventors:
Andrei Yurievich EGOROV, Boris FERKO, Artem Alexandrovich KROKHIN, Yulia Romanovna ROMANOVA